Clinical Trials on Prognosis of Neurological Outcome at 6 Months in Patients Undergoing Traumatic Brain Injury in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Prestige Biopharma Limited
- Chengdu Nuoen Biotechnologies, Inc.
- AIDS Council of New South Wales
- North Karelia Hospital District
- Women and children's hospital of Jiaxing university
- Veeda Oncology
- Neuregenix
- Equipe MiMes
- Nestor Soler Porcar, MD, PhD
- BayCare Health System
- Maria Lendorf
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Mononuclear Therapeutics Ltd.
- Centro di Procreazione Assistita Demetra
- Bjørgene Omsorgssenter, Haugesund
- InflaRx GmbH
- ImproveCareNow (ICN)
- Reina Sofia University Hospital
- Bruce County Paramedic Service
- Grand Challenges Canada
- View Full List
Medical Conditions
- Spine Surgeries
- Fracture Dislocation of Cervical Spine
- Closure; Foramen Ovale
- Ewing's Family Tumors
- Multisystem Proteinopathy
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Tay-Sachs Disease Ganglioside
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Childhood Langerhans Cell Histiocytosis
- Epidemic Hemorrhagic Fever
- Chlamydophila Infections
- Psoriasis, Arthritic
- Skull Base Neoplasms
- Fetus or Neonate Affected by External Version Before Labor
- Painless Hysteroscopy
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Predictors of Atrial Fibrillation Recurrences
- Gullian Barre Syndrome
- Pulmonary Adenocarcinoma
- Endocarditis Infective
- View Full List
Drug Interventions
- Palliative care group first-line scheme
- Vehicle
- Esomeprazole 40mg before
- Cereport
- Semapimod
- EFV +TVA
- Adapalene Gel 0.3%
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Chemotherapeutic Agent
- Neihulizumab
- Redifferentiation with retinoid acid
- Azelastine hydrochloride (BAYR9258)
- Estradiol+Drospirenone
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- High dose pantoprazole infusion
- Qingkailing injection 40 ml
- Glimepiride
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Adriamycin
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Belarus
- Contract Research Organizations in Colombia
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Denmark
- Contract Research Organizations in Gabon
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Pakistan
- Contract Research Organizations in South Africa
- Contract Research Organizations in Spain
- Contract Research Organizations in Sri Lanka
- CRO list by country